A novel, potent, and long-lasting dipeptidyl peptidase-4 inhibitor, teneligliptin, improves postprandial hyperglycemia and dyslipidemia after single and repeated administrations - Fukuda-Tsuru, S; Anabuki, J; Abe, Y (Eur J Pharmacol, 2012)
et al.